GS
Gurnam Singh
About Gurnam Singh
Gurnam Singh has 8 years in corporate governance. Holds Director and Designated Partner roles. Currently with 2 companies, including Mondovet Biotech Private Limited and Leapx Infotech Limited Liability Partnership. Formerly with 2 companies, such as Ggynex Pharma Private Limited and Zemilon Biotech Private Limited. Engaged in Technology, General Business. Contributes to corporate operations.
Current companies
| Company | Designation | Appointment | Founded | Status |
|---|---|---|---|---|
Mondovet Biotech Private Limited
U24100HR2021PTC094454
|
Director | 14 Apr 2021 | 2021 | Active |
| Designated Partner | 13 Dec 2017 | 2017 | Active |
Previous companies
| Company | Designation | Appointment | Founded | Status |
|---|---|---|---|---|
Ggynex Pharma Private Limited
U46497HR2022PTC104654
|
Additional Director | 02 Aug 2022 | 2022 | Active |
Zemilon Biotech Private Limited
U24290HR2022PTC105914
|
Director | 20 Aug 2022 | 2022 | Active |
Explore Director's current and past company associations Uncover their professional journey today!
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Gurnam Singh
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Gurnam Singh
Gurnam Singh has 8 years in corporate governance. Holds Director and Designated Partner roles. Currently with 2 companies, including Mondovet Biotech Private Limited and Leapx Infotech Limited Liability Partnership. Formerly with 2 companies, such as Ggynex Pharma Private Limited and Zemilon Biotech Private Limited. Engaged in Technology, General Business. Contributes to corporate operations.
Gurnam Singh is associated with 2 companies as Director and Designated Partner.
Gurnam Singh has expertise in Technology, General Business.
Gurnam Singh has 8 years in corporate governance.